Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review

10.1371/journal.pone.0077901

Saved in:

Bibliographic Details
Main Authors:	Rui Y.-Y., Zhang D., Zhou Z.-G., Wang C., Yang L., Yu Y.-Y., Chen H.-N.
Other Authors:	ELECTRICAL AND COMPUTER ENGINEERING
Format:	Article
Published:	2019
Subjects:	antineoplastic agent fluorouracil folinic acid irinotecan levamisole oxaliplatin adjuvant therapy article cancer prognosis cancer staging case control study cohort analysis colorectal cancer denaturing gradient gel electrophoresis disease free survival gene mutation human long term survival meta analysis oncogene K ras overall survival polymerase chain reaction pyrosequencing quality control restriction fragment length polymorphism sample size single strand conformation polymorphism systematic review Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Colorectal Neoplasms Humans Mutation Prognosis Proto-Oncogene Proteins ras Proteins Survival Rate Tumor Markers, Biological
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161460
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161460
record_format	dspace
spelling	sg-nus-scholar.10635-1614602024-04-25T03:36:11Z Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review Rui Y.-Y. Zhang D. Zhou Z.-G. Wang C. Yang L. Yu Y.-Y. Chen H.-N. ELECTRICAL AND COMPUTER ENGINEERING antineoplastic agent fluorouracil folinic acid irinotecan levamisole oxaliplatin adjuvant therapy article cancer prognosis cancer staging case control study cohort analysis colorectal cancer denaturing gradient gel electrophoresis disease free survival gene mutation human long term survival meta analysis oncogene K ras overall survival polymerase chain reaction pyrosequencing quality control restriction fragment length polymorphism sample size single strand conformation polymorphism systematic review Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Colorectal Neoplasms Humans Mutation Prognosis Proto-Oncogene Proteins ras Proteins Survival Rate Tumor Markers, Biological 10.1371/journal.pone.0077901 PLoS ONE 8 10 e77901 2019-11-05T02:11:29Z 2019-11-05T02:11:29Z 2013 Article Rui Y.-Y., Zhang D., Zhou Z.-G., Wang C., Yang L., Yu Y.-Y., Chen H.-N. (2013). Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review. PLoS ONE 8 (10) : e77901. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0077901 1932-6203 https://scholarbank.nus.edu.sg/handle/10635/161460 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	antineoplastic agent fluorouracil folinic acid irinotecan levamisole oxaliplatin adjuvant therapy article cancer prognosis cancer staging case control study cohort analysis colorectal cancer denaturing gradient gel electrophoresis disease free survival gene mutation human long term survival meta analysis oncogene K ras overall survival polymerase chain reaction pyrosequencing quality control restriction fragment length polymorphism sample size single strand conformation polymorphism systematic review Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Colorectal Neoplasms Humans Mutation Prognosis Proto-Oncogene Proteins ras Proteins Survival Rate Tumor Markers, Biological
spellingShingle	antineoplastic agent fluorouracil folinic acid irinotecan levamisole oxaliplatin adjuvant therapy article cancer prognosis cancer staging case control study cohort analysis colorectal cancer denaturing gradient gel electrophoresis disease free survival gene mutation human long term survival meta analysis oncogene K ras overall survival polymerase chain reaction pyrosequencing quality control restriction fragment length polymorphism sample size single strand conformation polymorphism systematic review Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Colorectal Neoplasms Humans Mutation Prognosis Proto-Oncogene Proteins ras Proteins Survival Rate Tumor Markers, Biological Rui Y.-Y. Zhang D. Zhou Z.-G. Wang C. Yang L. Yu Y.-Y. Chen H.-N. Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
description	10.1371/journal.pone.0077901
author2	ELECTRICAL AND COMPUTER ENGINEERING
author_facet	ELECTRICAL AND COMPUTER ENGINEERING Rui Y.-Y. Zhang D. Zhou Z.-G. Wang C. Yang L. Yu Y.-Y. Chen H.-N.
format	Article
author	Rui Y.-Y. Zhang D. Zhou Z.-G. Wang C. Yang L. Yu Y.-Y. Chen H.-N.
author_sort	Rui Y.-Y.
title	Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
title_short	Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
title_full	Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
title_fullStr	Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
title_full_unstemmed	Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
title_sort	can k-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? a meta-analysis and systematic review
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161460
_version_	1800913795820814336

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review

Similar Items